Good morning :)
Place Order
Add to Watchlist

Thyrocare Technologies Ltd

THYROCARE

Thyrocare Technologies Ltd

THYROCARE
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹3,348 cr, stock is ranked 813
High RiskStock is 3.17x as volatile as Nifty
642.400.29% (-1.90)
642.400.29% (-1.90)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹3,348 cr, stock is ranked 813
High RiskStock is 3.17x as volatile as Nifty

How to use scorecard? Learn more

Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹3,348 cr, stock is ranked 813
High RiskStock is 3.17x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
51.066.262.85%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.185.820.57%

Forecast & Ratings

Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 1 analyst

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Thyrocare Technologies Limited is a diagnostic chain company which offers a range of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases.

Investor Presentation

View older 

Aug 1, 2023

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 7.17%, vs industry avg of 13.8%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 1.18% to 0.84%

Loading...

Financial YearFY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023TTM
Total Revenue191.07247.51316.63379.32413.52441.44507.05618.11536.27564.02
Raw Materialssubtract55.9369.6881.7894.61110.79117.17163.86170.57163.03425.20
Power & Fuel Costsubtract3.955.326.356.687.778.697.648.4010.71
Employee Costsubtract17.4825.7032.0035.3443.3548.9258.0761.13106.15
Selling & Administrative Expensessubtract20.7628.8946.1449.5759.2744.4842.1645.4751.69
Operating & Other expensessubtract12.1717.3350.1727.5927.5048.0151.7067.7472.56
Depreciation/Amortizationsubtract12.8718.2418.0520.1026.1731.9130.2833.8738.7144.75
Interest & Other Itemssubtract0.300.550.460.440.611.850.873.214.833.75
Taxes & Other Itemssubtract22.4030.0038.8351.7152.9252.0139.3251.5824.2324.73
EPS9.609.947.9817.3615.9916.7421.4133.3012.1612.39
DPS15.2810.0010.0010.0020.005.0025.0015.0018.0018.00
Payout ratio1.591.011.250.581.250.301.170.451.481.45

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2021

Annual report

PDF

Investor Presentation

May 10PDF
FY 2022

Annual report

PDF

Investor Presentation

Apr 30PDF
Feb 12PDF
Feb 12PDF
+2 more
FY 2023

Annual report

PDF

Investor Presentation

Feb 3PDF
Nov 11PDF
Aug 1PDF
FY 2024

Annual Report Pending

Investor Presentation

Aug 1PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Thyrocare Technologies Ltd52.036.262.85%
Apollo Hospitals Enterprise Ltd108.3013.580.24%
Max Healthcare Institute Ltd68.0710.140.13%
Global Health Ltd115.5815.52

Price Comparison

Compare THYROCARE with any stock or ETF
Compare THYROCARE with any stock or ETF
THYROCARE
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding

Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding71.11%12.94%1.94%2.90%11.10%

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Shareholding History

Dec '22MarJunSepDec '23Mar10.13%10.00%3.44%3.46%3.35%2.90%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Thyrocare Technologies Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Nippon India SMALL CAP FUND DIRECT PLAN GROWTH PLAN GROWTH

Growth
3.1326%0.23%-0.03%147/218 (-5)
Nippon India PHARMA FUND DIRECT PLAN GROWTH PLAN - GROWTH OPTION GROWTH

Growth
3.1137%1.46%-0.29%24/36 (-1)
ICICI PRUDENTIAL INDIA OPPORTUNITIES FUND DIRECT PLAN GROWTH

Growth
1.9283%0.38%-0.12%63/86 (-9)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 2.85%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹28.45 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateApr 20, 2023

Interim
Interim | Div/Share: ₹18.00

Dividend/Share

18.00

Ex DateEx Date

Apr 20, 2023

Cash Dividend

Ex DateEx DateMay 11, 2022

Interim
Interim | Div/Share: ₹15.00

Dividend/Share

15.00

Ex DateEx Date

May 11, 2022

Cash Dividend

Ex DateEx DateJun 17, 2021

Final
Final | Div/Share: ₹15.00

Dividend/Share

15.00

Ex DateEx Date

Jun 17, 2021

Cash Dividend

Ex DateEx DateNov 12, 2020

Interim
Interim | Div/Share: ₹10.00

Dividend/Share

10.00

Ex DateEx Date

Nov 12, 2020

Cash Dividend

Ex DateEx DateNov 21, 2019

Interim
Interim | Div/Share: ₹5.00

Dividend/Share

5.00

Ex DateEx Date

Nov 21, 2019